78
Depkes RI, 2006. Buku Saku Hipertensi, http:www.academia.edu7994928
PHARMACEUTICAL_CARE_UNTUK_PENYAKIT_HIPERTENSI ,
Diakses pada 7 Oktober 2015
Draznin, Boris., and Epstein, Sol., 2011. Oxford American Haandbook of Endrokinology and Diabetes
, New York: Oxford University Press, p 585. Dussol,
B et.al., 2012. A Randomized trial of furosemide vs
hydrochlorothiazide in patients with chronic renal failure and hypertension “, Vol.2, p.349.
Effendi, Ian., dan Pasaribu, Restu., 2009. Edema Patofisiologi dan Penanganan. In: Sudoyo, Aru.W., Setyohadi, B., Alwi, I., Simadibrata, Marcellus. K,.
Setiati, S Eds. Buku Ajar Ilmu Penyakit Dalam Jilid II dan Jilid III. Edisi ke-5, Jakarta: Internal Publishing. hal 946.
Elmarakby, Ahmed A., Sullivan, Jennifer C., 2010. Relationship between Oxidative
Stress and
Inflammatory Cytokines
in Diabetic
Nephropathy , http:www.ncbi.nlm.nih.govpubmed20718759, Diakses
tanggal 14 September 2015.
FDA., 2012. Telmisartan, Olmesartan, Eprosartan, http:www.accessdata.fda.
govdrugsatfdadocslabel2012020850s036lbl.pdf , Diakses 15 November 2015.
Fried, F.Linda et.al., 2013. Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy. Nephrology, Vol. 20 No. 369, p. 1903-1892.
Haneda,Masakazu et.al., 2015. A new Clasification of Diabetic Nephropathy
2014: a report from Joint Commite on Diabetic Nephropathy. Journal of Diabetes Investigation
, Vol.6 No.2, p.242-246. Hsieh,
MC et.al.,
2011. Remission
of diabetic nephropathy in
type 2 diabetic Asian population: role of tight glucose and blood pressure
control. World Journal of Nephrology, Vol. 8, p. 2362-1365.
Huang, RS et.al., 2016. Renoprotective Effect of the Combination of Renin angiotensin System Inhibitor and Calcium Channel Blocker in Patients
with Hypertension and Chronic Kidney Disease. Chinese Medical Journal, Vol.129 No.5, p.562-569
ISO., 2011. Informasi Spesialis Obat. Jakarta: PT. ISFI Penerbitan.
79
Infodatin., 2014. Pusat Data dan Informasi Kementrian Kesehatan RI, http:
www.depkes.go.idfolderview01structure-publikasi-pusdatin-info- datin.html , Diakses pada 25 November 2015.
Joy, Melanie.S., Kshirsagar, A., Franceshini, N., 2009. Chronic Kidney Disease: Progression-Modifying Therapies. In: Joseph t.Dipiro, Robert.L.T, Gary
C.Yee, Gary R, Barbara G.W, L. Michael.P Eds. Pharmacotherapy A Pathophysiologic Approach,
Ed.7th, United States of America: McGraw- Hill Companies Inc., pp.745.
Kanwar, YS., Lin, S., Xie, P., Chen, Sheldon., 2011. A Glimpse of Various Pathogenetic Mechanism of Diabetic Nephropathy. In: Eric Wong, and
Sultan Chaudhry. Nephrology, Vol.6, p. 423-395.
Katzung, Betram .G., 2007. Farmakologi Dasar dan Klinik. Edisi ke-10, Jakarta:Penerbit Buku Kedokteran EGC.
KDOQI., 2012. NKF KDOQI Guidelines, http:www2.kidney.orgprofessionals
KDOQIguidelines_ckdtoc.htm , Diakses 16 November 2015.
Khan, Gabriel. M., 2015. Cardiac Drug Therapy. Edisi ke-8, Ottawa:Humana
Press. Klein, Jon., 2012. Biomarkers That Predict Diabetic Nephropathy: The Long
Road From Finding Targets to Clinical Use. Diabetes Journals, Vol. 61, p.3073-3072
Kobori, Hiroyuki., Mori, H., Masaki, T., Nishiyama., 2013. Angiotensin II
Blockade and Renal Protection. Nephrology, Vol.16, p. 1- 20.
Kompas., 2013.
Pasien Cuci
Darah Terus
Meningkat,
http:health.kompas.comread201306261640186Pasien.Cuci.Darah.Te rus.Meningkat , Diakses pada 30 April 2016
Krol, D. Gregory., 2011. Chronic Kidney Disease, https:www.asn online.orgeducationtrainingfellowsHFHS_CKD_V6.pdf , Diakses pada
15 November 2015.
Kurts, C., Panzer, Ulf., Anders, H.J., Rees, Andree.J., 2013. Basic Kidney Anatomy and Physiology,
http:www.nature.comnrijournalv13n10boxnri3 523BX1.html, Diakses pada 23 November 2015.
80
Kosnadi Lidya., 2002. Nefropati Diabetik. In: Husein Alatas, Taralan T,.,
Partini.P, Sudung.O.Pardede Eds. Buku Ajar Nefrologi Anak. Edisi ke- 2, Jakarta: Penerbit FKUI.
Lacy, Charles.F
et.al., 2009.
Drug Handbook
Information,
http:webstore.lexi.com Drug-Information-Handbook , Diakses pada 10 November 2015.
Lehnhardt, Anja., and Kemper, Markus.J., 2011. Pathogenesis, Diagnosis and Management of Hyperkalemia
, Vol. 26 No.3, p. 377-384.
Leon, Shargel., Wu-Pong, S., Yu, Andrew,B.C., 2005. Biofarmasetika and Farmakokinetika Terapan
. Edisi ke- 5, Surabaya: Universitas Airlangga.
Levin, Adeeraa et.al., 2008. Guidelines for the management of chronic kidney disease
, Vol. 179 No.11, p.1154-1162.
Lopez, Revuelta.K et.al., 2014. World Journal of Nephrology. Silent Diabetic Nephropathy
. Vol. 3 No.1, p75-84. Lubis, Harun R.., Tessy, A., Hendromartono., Siregar, Parlindungan., 2009.
Penyakit Ginjal Diabetik In: Sudoyo, Aru.W., Setyohadi, B., Alwi, I., Simadibrata, Marcellus. K,. Setiati, S Eds. Buku Ajar Ilmu Penyakit
Dalam Jilid II dan Jilid III. Edisi ke-5, Jakarta: Internal Publishing. hal
979, 1086 dan 1942. Luker, Jennifer.R et.al., 2014. Management of Chronic Kidney Disease, UMHS
